Last reviewed · How we verify
Recombivax HB vaccine
Recombivax HB vaccine is a vaccine Biologic drug developed by Merck Sharp & Dohme LLC. It is currently in Phase 3 development for Prevention of hepatitis B infection in adults and children.
Recombivax HB vaccine stimulates an immune response to the hepatitis B virus.
Recombivax HB vaccine stimulates an immune response to the hepatitis B virus. Used for Prevention of hepatitis B infection in adults and children.
At a glance
| Generic name | Recombivax HB vaccine |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
This is achieved through the introduction of the hepatitis B surface antigen and core antigen, which triggers the body's immune system to produce antibodies and immune cells that can recognize and attack the virus.
Approved indications
- Prevention of hepatitis B infection in adults and children
Common side effects
- Pain, redness, swelling, or itching at the injection site
Key clinical trials
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PHASE3)
- HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders (PHASE4)
- Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) (PHASE3)
- A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) (PHASE3)
- A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers (PHASE2)
- Effects of Persistent Innate Immune Activation on Vaccine Efficacy (PHASE4)
- Hepatitis B Vaccine in Seniors (EARLY_PHASE1)
- A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombivax HB vaccine CI brief — competitive landscape report
- Recombivax HB vaccine updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI
Frequently asked questions about Recombivax HB vaccine
What is Recombivax HB vaccine?
How does Recombivax HB vaccine work?
What is Recombivax HB vaccine used for?
Who makes Recombivax HB vaccine?
What drug class is Recombivax HB vaccine in?
What development phase is Recombivax HB vaccine in?
What are the side effects of Recombivax HB vaccine?
Related
- Drug class: All vaccine drugs
- Manufacturer: Merck Sharp & Dohme LLC — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of hepatitis B infection in adults and children
- Compare: Recombivax HB vaccine vs similar drugs
- Pricing: Recombivax HB vaccine cost, discount & access